Stay updated on Nivolumab in AML Remission at High Risk Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in AML Remission at High Risk Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in AML Remission at High Risk Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:47:27.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and deleted Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:33:23.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    - Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:51:49.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and older revision notices (v3.4.1) were removed, along with a government funding status notice; these are site housekeeping changes that do not alter the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T11:47:51.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Administrative updates were added: a government funding notice and revision to v3.4.1 replacing v3.4.0, which do not affect core trial content or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:38:54.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The updates are minor UI and metadata changes (Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0) that do not alter the core study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:36:37.000Z thumbnail image

Stay in the know with updates to Nivolumab in AML Remission at High Risk Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in AML Remission at High Risk Clinical Trial page.